ImmunoEngineering (@ImmunoEngineers) header
ImmunoEngineering (@ImmunoEngineers) profile picture

ImmunoEngineering

@ImmunoEngineers

ImmunoEngineering Lab @KingsCollegeLon

 King's College London
kcl.ac.uk/people/sophie-papa
Joined May 2020
  • Tweets21
  • Following37
  • Followers51
2Media
Photo by ImmunoEngineering (@ImmunoEngineers)Photo by ImmunoEngineering (@ImmunoEngineers)
Targeting SLC3A2 with novel immune therapy strategies. #cancer #immunotherapy #CART #IgE #JITC pubmed.ncbi.nlm.nih.gov/3411…
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2 - PubMed

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2 - PubMed

These findings identify efficacious and potentially safe tumor-targeting of SLC3A2 with novel immune-activating antibody and genetically modified cell therapies.

pubmed.ncbi.nlm.nih.gov
1
ImmunoEngineering retweeted
NCRI Partnership (@NCRI_partners) profile picture
NCRI Partnership@NCRI_partners4 Jun 2021
Join us on 21 June to hear from #NobelPrize winner Dr James Allison as he discusses his incredible contributions to #immunology research at our next #NCRIPrime session! Register here: bit.ly/3vVnSbs
4
1
5
Safety and immunogenicity of one versus two doses of the COVID-19 vacc... sciencedirect.com/science/ar… data from Irshad and Hayday labs at KCL and Crick.
"Immune checkpoints inhibitors-associated #AKI: A single-center study" by @GSTTnhs @GSTTresearch, is available at the 𝗣𝗢𝗦𝗧𝗘𝗥𝗦 area on the 𝗩𝗜𝗥𝗧𝗨𝗔𝗟 #ISNWCN theisn.org/wcn
Image from World Congress of Nephrology (@ISNWCN)
1
6
4
ImmunoEngineering retweeted
Antibodies MDPI (@Antibodies_MDPI) profile picture
Antibodies MDPI@Antibodies_MDPI17 Mar 2021
Welcome to read the latest publication from Dr. Erin Runbeck and Dr. Sophie Papa, titled "Utilizing #Immunocytokines for #Cancer Therapy" . @KingsCollegeLon More details at: mdpi.com/2073-4468/10/1/10
Image from Antibodies MDPI (@Antibodies_MDPI)
1
1
Crucial work from the team at KCL using longitudinal immune phenotyping to demonstrate different immune responses to #COVID19 in some cancer patients.
The Francis Crick Institute (@TheCrick) profile pictureThe Francis Crick Institute@TheCrick5 Jan 2021
A new @CRUKresearch study out in @Cancer_Cell by @HaydayLab and @KingsCollegeLon, reveals striking differences in the immune response to #COVID19 in people with blood #cancers crick.ac.uk/news/2021-01-05_…
Immune response to COVID-19 reduced in patients with blood cancers

Immune response to COVID-19 reduced in patients with blood cancers

Patients with blood cancers such as leukaemia vary in their immune response to COVID-19 and can struggle to clear infection for very many weeks.

crick.ac.uk
4
5
Did you miss Eva’s Instagram takeover? Available here 👉🏼instagram.com/s/aGlnaGxpZ2h0…
Barts Cancer Institute (Queen Mary) (@QMBCI) profile pictureBarts Cancer Institute (Queen Mary)@QMBCI12 Oct 2020
📢 INSTAGRAM TAKEOVER TOMORROW 📢 Head over to our Instagram page tomorrow (13th Oct) instagram.com/qmbci where @CRUKCOLcentre PhD student Eva will be taking over. Tune in to find out about Eva's #cancerresearch and to ask her some questions!
Image from Barts Cancer Institute (Queen Mary) (@QMBCI)
4
4
.......and we're back!
Image from ImmunoEngineering (@ImmunoEngineers)
2
3
although we had to say goodbye to some new friends that have grown in our absence. Picture of the the water bath not included as people may be eating....🤢
Image from ImmunoEngineering (@ImmunoEngineers)
1
2
Our PhD student @BugalloEva is a semi-finalist with a graphical abstract about cell labelling strategies for nuclear imaging. Check it out 👇 app.biorender.com/contest/pr….

BioRender

BioRender is an online tool for creating beautiful, professional science figures in minutes.

app.biorender.com
BioRender (@BioRender) profile pictureBioRender
@BioRender12 Jun 2020
We’ve just announced 600 semifinalists in our graphical abstract contest, hand-picked by expert judges! 📣 Check out all semifinalists in our gallery. Remember to vote for your favorites & help them take home People’s Choice Award! 🏆 #academicchatter app.biorender.com/contest/ga…
1
2
Prevalence of asymptomatic SARS-CoV-2 in a south London Cancer Centre population frontiersin.org/articles/10.…
ImmunoEngineering retweeted
Shahram Kordasti (@KordastiL) profile picture
Shahram Kordasti@KordastiL29 May 2020
Very excited about our new clinical trial, using JAK inhibitor for COVID-19 kcl.ac.uk/news/trial-repurpo…

Trial to repurpose cancer drug for patients with COVID-19 launches | King's College London

A new trial repurposing a blood cancer drug for patients with COVID-19 is being launched.

kcl.ac.uk
1
If we want to understand COVID-19 we need to do quality immune monitoring in clinical trials #Kordasti lab kcl.ac.uk/news/trial-repurpo…

Trial to repurpose cancer drug for patients with COVID-19 launches | King's College London

A new trial repurposing a blood cancer drug for patients with COVID-19 is being launched.

kcl.ac.uk
1
@KordastiL
Even with our lab closed, we've been contributing in lots of ways to help combat #COVID19 and the impacts of this pandemic.
1
more replies
@robpagebio has been working with @rociotmartinez to establish on-site SARS-CoV-2 testing at Guy's Hospital. Their pre-print on resilient diagnostic workflows is up on @medrxivpreprint medrxiv.org/content/10.1101/…
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation

Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation

There is a worldwide shortage of reagents to perform detection of SARS-CoV-2. Many clinical diagnostic laboratories rely on commercial platforms that provide integrated end-to-end solutions. While...

medrxiv.org
1
2
@BugalloEva is working with @HaydayLab in the Covid-IP project, immunophenotyping samples from patients infected with SARS-CoV-2 to gain a better understanding on patients’ immune response and symptoms experienced. Learn more immunophenotype.org/
1
Hello world! What better time to start twittering than a lockdown? We can't be in the lab at the moment, but in the meantime we can't wait to connect with the academia twitterverse and share some interesting things!
1
1
Load more